{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:27:53Z","timestamp":1787506073175,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.rmed.2026.108640","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T16:10:00Z","timestamp":1767715800000},"page":"108640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Blood eosinophilia as a predictor of acute exacerbation in fibrotic interstitial lung diseases"],"prefix":"10.1016","volume":"252","author":[{"given":"M\u00e9lanie","family":"David","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0055-0972","authenticated-orcid":false,"given":"Quentin","family":"Marquant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4447-7850","authenticated-orcid":false,"given":"Anne-Laure","family":"Brun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kewin","family":"Panel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Chabrol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9294-5340","authenticated-orcid":false,"given":"Helene","family":"Salvator","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Magnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0810-136X","authenticated-orcid":false,"given":"Matthieu","family":"Groh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colas","family":"Tcherakian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.rmed.2026.108640_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02419-2016","article-title":"Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris","volume":"50","author":"Duchemann","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2026.108640_bib2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1183\/09031936.00159709","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome","volume":"37","author":"Song","year":"2011","journal-title":"Eur. Respir. J."},{"issue":"18","key":"10.1016\/j.rmed.2026.108640_bib3","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.rmed.2026.108640_bib4","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis-associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.rmed.2026.108640_bib5","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2026.108640_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0020-2015","article-title":"The regulatory function of eosinophils","volume":"4","author":"Wen","year":"2016","journal-title":"Microbiol. Spectr."},{"issue":"4","key":"10.1016\/j.rmed.2026.108640_bib7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2222.2010.03484.x","article-title":"Eosinophils in health and disease: the LIAR hypothesis","volume":"40","author":"Lee","year":"2010","journal-title":"Clin. Exp. Allergy"},{"issue":"22","key":"10.1016\/j.rmed.2026.108640_bib8","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1056\/NEJM197505292922204","article-title":"Total eosinophil counts in the management of bronchial asthma","volume":"292","author":"Horn","year":"1975","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.rmed.2026.108640_bib9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","article-title":"Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials","volume":"3","author":"Pascoe","year":"2015","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.108640_bib10","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1164\/rccm.202303-0455CI","article-title":"Targeting type 2 inflammation and epithelial alarmins in chronic obstructive pulmonary disease: a biologics outlook","volume":"208","author":"Rabe","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"17","key":"10.1016\/j.rmed.2026.108640_bib11","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMoa1708208","article-title":"Mepolizumab for eosinophilic chronic obstructive pulmonary disease","volume":"377","author":"Pavord","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108640_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.immuni.2018.04.023","article-title":"Amphiregulin-producing pathogenic memory T helper 2 cells instruct eosinophils to secrete osteopontin and facilitate airway fibrosis","volume":"49","author":"Morimoto","year":"2018","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.rmed.2026.108640_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1378\/chest.92.1.51","article-title":"Prognostic role of eosinophils in pulmonary fibrosis","volume":"92","author":"Peterson","year":"1987","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.rmed.2026.108640_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nri3341","article-title":"Eosinophils: changing perspectives in health and disease","volume":"13","author":"Rosenberg","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.rmed.2026.108640_bib15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/jlb.64.5.657","article-title":"The role of IL-5 in bleomycin-induced pulmonary fibrosis","volume":"64","author":"Gharaee-Kermani","year":"1998","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.rmed.2026.108640_bib16","first-page":"43","article-title":"The role of eosinophils in pulmonary fibrosis","volume":"1","author":"Gharaee-Kermani","year":"1998","journal-title":"Int. J. Mol. Med."},{"issue":"21","key":"10.1016\/j.rmed.2026.108640_bib17","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"Prednisone, azathioprine, and N -Acetylcysteine for pulmonary fibrosis","volume":"366","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.108640_bib18","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1165\/rcmb.F301","article-title":"Back to the future","volume":"33","author":"Noble","year":"2005","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.rmed.2026.108640_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jbi.2018.02.019","article-title":"A clinician friendly data warehouse oriented toward narrative reports: r. Warehouse","volume":"80","author":"Garcelon","year":"2018","journal-title":"J. Biomed. Inf."},{"issue":"6","key":"10.1016\/j.rmed.2026.108640_bib20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American thoracic society\/European respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.rmed.2026.108640_bib21","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","article-title":"Diagnosis of hypersensitivity pneumonitis in adults. An official ATS\/JRS\/ALAT clinical practice guideline","volume":"202","author":"Raghu","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2026.108640_bib22","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1055\/s-2007-991527","article-title":"Bronchoalveolar lavage as a diagnostic tool","volume":"28","author":"Meyer","year":"2007","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.rmed.2026.108640_bib23","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report","volume":"194","author":"Collard","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2026.108640_bib24","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01874-2019","article-title":"Blood eosinophil count in the general population: typical values and potential confounders","volume":"55","author":"Hartl","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2026.108640_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2020.104023","article-title":"Adult interstitial lung diseases and their epidemiology","volume":"49","author":"Ses\u00e9","year":"2020","journal-title":"Presse Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.108640_bib26","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1183\/13993003.00419-2015","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm","volume":"46","author":"Ryerson","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.rmed.2026.108640_bib27","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S2213-2600(23)00259-X","article-title":"Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management","volume":"11","author":"Olsson","year":"2023","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2026.108640_bib28","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1378\/chest.10-2572","article-title":"Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium","volume":"140","author":"Nathan","year":"2011","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.rmed.2026.108640_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18618","article-title":"Factors associated with listing for lung transplantation in IPF patients: an analysis of the pulmonary fibrosis foundation registry","volume":"9","author":"King","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.rmed.2026.108640_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12931-016-0400-1","article-title":"Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis","volume":"17","author":"Kakugawa","year":"2016","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.rmed.2026.108640_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283288","article-title":"Diagnostic and prognostic biomarkers for progressive fibrosing interstitial lung disease","volume":"18","author":"Watase","year":"2023","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.rmed.2026.108640_bib34","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1164\/ajrccm\/139.2.373","article-title":"The eosinophil component of the alveolitis in idiopathic pulmonary fibrosis: signs of eosinophil activation in the lung are related to impaired lung function","volume":"139","author":"H\u00e4llgren","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"issue":"6","key":"10.1016\/j.rmed.2026.108640_bib35","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/resp.13234","article-title":"Co-morbidity and mortality among patients with interstitial lung diseases: a population-based study","volume":"23","author":"Hilberg","year":"2018","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.rmed.2026.108640_bib36","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/all.16463","article-title":"Hypereosinophilia and hypereosinophilic syndromes: first findings from a nationwide multicenter cohort","volume":"80","author":"Lef\u00e8vre","year":"2025","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2026.108640_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.875887","article-title":"Immunophenotyping of acute inflammatory exacerbations of lung injury driven by mutant surfactant Protein-C: a role for inflammatory eosinophils","volume":"13","author":"Nguyen","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.rmed.2026.108640_bib38","doi-asserted-by":"crossref","first-page":"8120","DOI":"10.1038\/s41467-023-43336-6","article-title":"Activation of ILC2s through constitutive IFN\u03b3 signaling reduction leads to spontaneous pulmonary fibrosis","volume":"14","author":"Otaki","year":"2023","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.rmed.2026.108640_bib39","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S2213-2600(19)30356-X","article-title":"Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study","volume":"8","author":"Verleden","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"429","key":"10.1016\/j.rmed.2026.108640_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0333","article-title":"Eosinophil depletion suppresses radiation-induced small intestinal fibrosis","volume":"10","author":"Takemura","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.108640_bib41","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1189\/jlb.68.4.515","article-title":"Bleomycin-induced pulmonary fibrosis is independent of eosinophils","volume":"68","author":"Hao","year":"2000","journal-title":"J. Leukoc. Biol."},{"issue":"11","key":"10.1016\/j.rmed.2026.108640_bib42","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/ajh.25945","article-title":"Epidemiology, clinical picture and long-term outcomes of FIP1L1-PDGFRA-positive myeloid neoplasm with eosinophilia: data from 151 patients","volume":"95","author":"Rohmer","year":"2020","journal-title":"Am. J. Hematol."},{"issue":"6","key":"10.1016\/j.rmed.2026.108640_bib43","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/ajh.27306","article-title":"Involvement of the JAK-STAT pathway in the molecular landscape of tyrosine kinase fusion-negative hypereosinophilic syndromes: a nationwide CEREO study","volume":"99","author":"Groh","year":"2024","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.rmed.2026.108640_bib44","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1183\/13993003.00097-2016","article-title":"Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","volume":"48","author":"Cottin","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"163","key":"10.1016\/j.rmed.2026.108640_bib45","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0150-2021","article-title":"Eosinophils and eosinophilic immune dysfunction in health and disease","volume":"31","author":"Jackson","year":"2022","journal-title":"Eur. Respir. Rev."},{"issue":"20","key":"10.1016\/j.rmed.2026.108640_bib46","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1056\/NEJMoa044113","article-title":"Asthma as a risk factor for invasive pneumococcal disease","volume":"352","author":"Talbot","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.108640_bib47","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jaci.2014.04.024","article-title":"Risks for infection in patients with asthma (or other atopic conditions): is asthma more than a chronic airway disease?","volume":"134","author":"Juhn","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.rmed.2026.108640_bib48","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.chest.2017.03.033","article-title":"The role of infection in interstitial lung diseases: a review","volume":"152","author":"Azadeh","year":"2017","journal-title":"Chest"},{"issue":"150","key":"10.1016\/j.rmed.2026.108640_bib49","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0071-2018","article-title":"Acute exacerbations of progressive-fibrosing interstitial lung diseases","volume":"27","author":"Kolb","year":"2018","journal-title":"Eur. Respir. Rev."},{"issue":"2","key":"10.1016\/j.rmed.2026.108640_bib50","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","article-title":"An official ATS\/ERS\/JRS\/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline","volume":"192","author":"Raghu","year":"2015","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"Suppl 2","key":"10.1016\/j.rmed.2026.108640_bib51","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s13023-021-01844-y","article-title":"French recommendations for the management of systemic sclerosis","volume":"16","author":"Hachulla","year":"2021","journal-title":"Orphanet J. Rare Dis."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126000089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611126000089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T03:14:17Z","timestamp":1771730057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611126000089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":49,"alternative-id":["S0954611126000089"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108640","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood eosinophilia as a predictor of acute exacerbation in fibrotic interstitial lung diseases","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.108640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108640"}}